RxDoctor Payments Data

John Labs, PA

Physician Assistant · Charlotte, NCNPI 1255314134

Payments from drug & device makers

$7,293in general payments, 2019–2025

Across 421 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Collegium Pharmaceutical, Inc.$1K
  • AbbVie$1K
  • Azurity Pharmaceuticals, Inc.$383
  • Pfizer$345
  • Merck$310
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$7,25199%
  • Education$421%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,293 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$190,654
Medicare patients
105
Services billed
2,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate304$140,860
RelistorMethylnaltrexone Bromide47$115,170
UbrelvyUbrogepant38$69,457
HorizantGabapentin Enacarbil64$66,299
PercocetOxycodone Hcl/Acetaminophen12$52,551
BelbucaBuprenorphine Hcl58$50,866
MovantikNaloxegol Oxalate111$49,741
OxycontinOxycodone Hcl92$45,356
Levorphanol Tartrate15$40,080
Nurtec OdtRimegepant Sulfate23$33,707
Oxycodone Hcl1,141$28,796
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen602$22,445
BelsomraSuvorexant32$13,666
ZtlidoLidocaine20$13,047
QuviviqDaridorexant Hcl20$11,712

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$1,201$191,726362 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,619$115,17047 claims
AbbVieUbrelvy, Savella$1,057$78,68053 claims
Arbor Pharmaceuticals, Inc.Horizant$270$66,29964 claims
Redhill Biopharma Inc.Movantik$141$49,741111 claims
PfizerNurtec Odt, Lyrica$345$40,36034 claims
Virtus Pharmaceuticals LLCLevorphanol Tartrate$72$40,08015 claims
MerckBelsomra$310$13,66632 claims
Scilex Pharmaceuticals Inc.Ztlido$202$13,04720 claims
Idorsia Pharmaceuticals US IncQuviviq$264$11,71220 claims
Hikma Pharmaceuticals USABuprenorphine, Epinephrine$109$7,21428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →